Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
Did Hedge Funds Make The Right Call On CareDx, Inc. (CDNA)?
01:40pm, Wednesday, 12'th Aug 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
CareDx Inc (NASDAQ:CDNA) CEO Sells $478,304.16 in Stock
01:54am, Tuesday, 11'th Aug 2020
CareDx Inc (NASDAQ:CDNA) CEO Peter Maag sold 13,008 shares of the company’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $36.77, for a total value
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
How Does CareDx's (NASDAQ:CDNA) CEO Pay Compare With Company Performance?
11:11am, Wednesday, 05'th Aug 2020
This article will reflect on the compensation paid to Peter Maag who has served as CEO of CareDx, Inc (NASDAQ:CDNA...
CareDx Inc (CDNA) Q2 2020 Earnings Call Transcript
06:01am, Wednesday, 05'th Aug 2020
Earlier today, CareDx released financial results for the quarter ended June 30, 2020. Peter Maag, Chief Executive Officer; and Michael Bell, Chief Financial Officer, will host this afternoon's call.
CareDx (CDNA) Q2 Earnings and Revenues Surpass Estimates
11:45pm, Tuesday, 04'th Aug 2020
CareDx (CDNA) delivered earnings and revenue surprises of 166.67% and 17.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
CareDx Reports Second Quarter 2020 Results
08:05pm, Tuesday, 04'th Aug 2020
Patient-focused during COVID-19 pandemic and succeedingSOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the d
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference
11:00am, Thursday, 30'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinic
3 Artificial Intelligence Stocks With Long-Term Narratives
02:20am, Saturday, 25'th Jul 2020
Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can
CareDx Inc (NASDAQ:CDNA) Shares Bought by Tiaa Fsb
08:36am, Friday, 17'th Jul 2020
Tiaa Fsb grew its stake in shares of CareDx Inc (NASDAQ:CDNA) by 4.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 77,491 shares of the company’s stock aft
CareDx to Report Second Quarter 2020 Financial Results
08:05pm, Thursday, 16'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 16, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx Chairman and CEO Peter Maag to Present at Global Kidney Innovations Summit
11:00am, Wednesday, 15'th Jul 2020
SOUTH SAN FRANCISCO, Calif., July 15, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of.
AQR Capital Management LLC Sells 38,532 Shares of CareDx Inc (NASDAQ:CDNA)
08:04am, Saturday, 11'th Jul 2020
AQR Capital Management LLC trimmed its position in CareDx Inc (NASDAQ:CDNA) by 75.2% during the first quarter, HoldingsChannel reports. The institutional investor owned 12,706 shares of the company’
